FMC Corp vs Prudential PLC — how do they compare? FMC Corp trades at $11.44 (market cap $1.36B), while Prudential PLC trades at $28.58 (market cap $35.24B). The key difference: Prudential PLC is far larger — about 25.9× FMC Corp's market cap, and FMC Corp pays the higher dividend (2.95%). Which is the better fit depends on your goals.
| FMC | PUK | |
|---|---|---|
Market Cap | $1.36B | $35.24B |
Sector | Basic Materials | Financials |
52-Week High | $43.90 | $33.61 |
52-Week Low | $10.72 | $24.65 |
Enterprise Value | $5.50B | $36.68B |
Dividend Yield | 2.95% | 1.83% |
Signals from Pluang's Aura AI — not financial advice
FMC Corporation (FMC) trades at $11.61, up 8.3% today, but remains in a challenging fundamental position with a net income margin of -72.93% and negative ROE of -80.78% for 2025. The company is actively restructuring, securing a $400 million minority investment from Tessenderlo Group and planning a $114 million property sale to reduce its $3.03 billion long-term debt. Technical indicators are bearish, with the stock trading near key support at $11. Recent news highlights progress on its new herbicide, rimisoxafen, including a regulatory submission to the EPA and a partnership with Corteva.
The outlook is cautious. While aggressive debt reduction and new product pipelines offer potential, deep losses and declining revenue pose significant risks. The analyst consensus is mixed (47.6% Buy, 50% Hold) with a $16 price target, suggesting modest upside if turnaround efforts succeed, but high execution risk remains the primary concern for investors.
Prudential PLC (PUK) trades at $28.59, showing stable daily performance with no change. The stock exhibits a bullish technical signal, supported by strong moving averages. Fundamentally, the company demonstrates robust profitability with a net income margin of 14.52% and ROE of 21.15%, while recent earnings beats in Q4 2025 and Q2 2025 highlight operational strength. Revenue has grown from $16.21B in 2024 to a projected $27.4B in 2025, though challenges persist in key markets like Japan.
The outlook for PUK is cautiously optimistic, driven by earnings growth and strategic expansions in Asia. However, risks include regulatory pressures in China and Japan, where sales suspensions could impact near-term performance. Analyst consensus leans bullish with 50% buy ratings, but investors should monitor geopolitical and regulatory developments that may affect the stock's trajectory.
Trailing returns across standard periods
FMC is a pure-play crop chemical company. The company has diversified its sales to create a balanced crop chemical portfolio across geographies and crop exposure. Through acquisitions, FMC is now one of the five largest patented crop chemical companies and will continue to develop new products, with a focus on biologicals, through its research and development pipeline.
Read more on FMC →Prudential is an Asia and Africa health and life insurance business and is focused on long-term savings. The business is increasingly focusing on digital offerings and creating strong brand equity and relationships with customers of its products through these.
Read more on PUK →